Research Analysts’ Updated EPS Estimates for September 27th (AORT, ARLO, ATXS, BB, COST, CRIS, CRNX, DFIN, ENLV, ENTA)

Research Analysts’ updated eps estimates for Friday, September 27th:

Artivion (NYSE:AORT) had its buy rating reaffirmed by analysts at Needham & Company LLC. They currently have a $30.00 target price on the stock.

Arlo Technologies (NYSE:ARLO) had its buy rating reiterated by analysts at BWS Financial. The firm currently has a $24.00 price target on the stock.

Astria Therapeutics (NASDAQ:ATXS) had its buy rating reissued by analysts at HC Wainwright. They currently have a $16.00 price target on the stock.

BlackBerry (NYSE:BB) had its sector perform rating reaffirmed by analysts at Royal Bank of Canada. They currently have a $3.00 price target on the stock.

Costco Wholesale (NASDAQ:COST) had its outperform rating reaffirmed by analysts at BMO Capital Markets. BMO Capital Markets currently has a $980.00 price target on the stock, up from their previous price target of $950.00.

Curis (NASDAQ:CRIS) had its buy rating reaffirmed by analysts at HC Wainwright. They currently have a $26.00 target price on the stock.

Crinetics Pharmaceuticals (NASDAQ:CRNX) had its market outperform rating reiterated by analysts at JMP Securities. JMP Securities currently has a $80.00 target price on the stock.

Donnelley Financial Solutions (NYSE:DFIN) had its buy rating reiterated by analysts at Needham & Company LLC. They currently have a $79.00 target price on the stock.

Enlivex Therapeutics (NASDAQ:ENLV) had its buy rating reiterated by analysts at HC Wainwright. The firm currently has a $6.00 target price on the stock.

Enanta Pharmaceuticals (NASDAQ:ENTA) had its market outperform rating reiterated by analysts at JMP Securities. The firm currently has a $22.00 price target on the stock.

Entera Bio (NASDAQ:ENTX) had its buy rating reaffirmed by analysts at HC Wainwright. They currently have a $10.00 price target on the stock.

Graco (NYSE:GGG) had its neutral rating reaffirmed by analysts at DA Davidson. They currently have a $79.00 price target on the stock.

Jasper Therapeutics (NASDAQ:JSPR) had its market outperform rating reissued by analysts at JMP Securities. JMP Securities currently has a $70.00 price target on the stock.

Kelly Services (NASDAQ:KELYA) had its outperform rating reissued by analysts at Barrington Research. They currently have a $29.00 target price on the stock.

Legend Biotech (NASDAQ:LEGN) had its outperform rating reiterated by analysts at Royal Bank of Canada. They currently have a $86.00 price target on the stock.

Levi Strauss & Co. (NYSE:LEVI) had its outperform rating reissued by analysts at Telsey Advisory Group. The firm currently has a $26.00 target price on the stock.

Lumos Pharma (NASDAQ:LUMO) had its buy rating reissued by analysts at HC Wainwright. They currently have a $28.00 price target on the stock.

Lexicon Pharmaceuticals (NASDAQ:LXRX) had its buy rating reiterated by analysts at HC Wainwright. The firm currently has a $10.00 target price on the stock.

Magnite (NASDAQ:MGNI) had its outperform rating reaffirmed by analysts at Royal Bank of Canada. Royal Bank of Canada currently has a $19.00 target price on the stock.

Matador Resources (NYSE:MTDR) had its outperform rating reiterated by analysts at Royal Bank of Canada. Royal Bank of Canada currently has a $75.00 price target on the stock.

Phreesia (NYSE:PHR) had its sector perform rating reissued by analysts at Royal Bank of Canada. The firm currently has a $23.00 price target on the stock.

Impinj (NASDAQ:PI) had its overweight rating reiterated by analysts at Piper Sandler. The firm currently has a $225.00 price target on the stock, up from their previous price target of $180.00.

REE Automotive (NASDAQ:REE) had its buy rating reaffirmed by analysts at HC Wainwright. They currently have a $15.00 target price on the stock.

Rezolute (NASDAQ:RZLT) had its buy rating reiterated by analysts at HC Wainwright. HC Wainwright currently has a $14.00 target price on the stock.

Sweetgreen (NYSE:SG) had its buy rating reaffirmed by analysts at TD Cowen. They currently have a $43.00 price target on the stock.

Smartsheet (NYSE:SMAR) had its neutral rating reaffirmed by analysts at Citigroup Inc.. The firm currently has a $56.50 price target on the stock, down from their previous price target of $63.00.

TD SYNNEX (NYSE:SNX) had its outperform rating reiterated by analysts at Royal Bank of Canada. The firm currently has a $140.00 target price on the stock.

Symbotic (NASDAQ:SYM) had its sell rating reissued by analysts at BWS Financial. BWS Financial currently has a $10.00 target price on the stock.

Talos Energy (NYSE:TALO) had its buy rating reissued by analysts at Benchmark Co.. The firm currently has a $20.00 target price on the stock.

Unum Group (NYSE:UNM) had its overweight rating reiterated by analysts at Piper Sandler. Piper Sandler currently has a $66.00 target price on the stock, up from their previous target price of $64.00.

Visa (NYSE:V) had its outperform rating reiterated by analysts at Macquarie. They currently have a $300.00 target price on the stock.

Zeta Global (NYSE:ZETA) had its buy rating reissued by analysts at Truist Financial Co.. Truist Financial Co. currently has a $35.00 target price on the stock, up from their previous target price of $30.00.